2019-nCoV Spike 重组蛋白|新冠病毒 Spike Protein (RBD, His Tag)

1, Wang Y, et al. SARS‐CoV‐2 S1 is superior to the RBD as a COVID‐19 subunit vaccine antigen.Journal of medical virology, PubMed ID: 32691875
2, Liu T, et al. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.Nature biomedical engineering, PubMed ID: 33122853
3, Mazzini L, et al. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.Journal of immunological methods, PubMed ID: 33253698
4, Asandei A, et al. Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit.ACS applied materials & interfaces, PubMed ID: 33270413
5, Pradenas E, et al. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes.Med (New York, N.Y.), PubMed ID: 33554155
6, Golden JW, et al. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.The Journal of general virology, PubMed ID: 33961540
7, Guo K, et al. Rapid single-molecule detection of COVID-19 and MERS antigens via nanobody-functionalized organic electrochemical transistors.Nature biomedical engineering, PubMed ID: 34031558
8, Schasfoort RBM, et al. High throughput surface plasmon resonance imaging method for clinical detection of presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during CoViD-19 infection.MethodsX, PubMed ID: 34221910
9, Tang J, et al. Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern.iScience, PubMed ID: 34430803
10, Wu K, et al. One-Step, Wash-free, Nanoparticle Clustering-Based Magnetic Particle Spectroscopy Bioassay Method for Detection of SARS-CoV-2 Spike and Nucleocapsid Proteins in the Liquid Phase.ACS applied materials & interfaces, PubMed ID: 34499464
11, Maghsood F, et al. Differential Antibody Response to SARS-CoV-2 Antigens in Recovered and Deceased Iranian COVID-19 Patients.Viral immunology, PubMed ID: 34534012
12, Egorov AI, et al. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.Microbiology spectrum, PubMed ID: 34523986
13, Wouters E, et al. A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasma.Transfusion, PubMed ID: 34498761
14, Tang J, et al. Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex.EBioMedicine, PubMed ID: 34902788
15, Qu JH, et al. Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood.ACS sensors, PubMed ID: 35061357
16, Dutt TS, et al. Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease.Journal of immunology (Baltimore, Md. : 1950), PubMed ID: 34987111
17, Fu Y, et al. Interfering effects on the bioactivities of several key proteins of COVID-19/variants in diabetes by compounds from Lianqiao leaves: In silico and in vitro analyses.International journal of biological macromolecules, PubMed ID: 35346677
18, Lee Y, et al. SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women.EBioMedicine, PubMed ID: 35301181
19, Wussow F, et al. COH04S1 and Beta Sequence Modified Vaccine Protect Hamsters From SARS-CoV-2 Variants.iScience, PubMed ID: 35634578
20, Bixler SL, et al. Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model.Viruses, PubMed ID: 35632755
21, Zimmerman O, et al. mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes.Cell Reports Medicine, PubMed ID: 35688161
22, Emmenegger M, et al. Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants.iScience, PubMed ID: 35875683
23, Wu F, et al. Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity.Acta pharmaceutica Sinica. B, PubMed ID: 35846427
24, Chiuppesi F, et al. Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants.iScience, PubMed ID: 35846380
25, Besselink G, et al. Asymmetric Mach-Zehnder Interferometric Biosensing for Quantitative and Sensitive Multiplex Detection of Anti-SARS-CoV-2 Antibodies in Human Plasma.Biosensors, PubMed ID: 35892450
26, Koklu A, et al. Convection Driven Ultrarapid Protein Detection via Nanobody-Functionalized Organic Electrochemical Transistors.Advanced materials (Deerfield Beach, Fla.), PubMed ID: 35772173
27, Hawman DW, et al. Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine.EBioMedicine, PubMed ID: 35932641
28, Lu JG, et al. Structures, biomimetic synthesis, and anti-SARS-CoV-2 activity of two pairs of enantiomeric phenylpropanoid-conjugated protoberberine alkaloids from the rhizomes of Corydalis decumbens.Archives of pharmacal research, PubMed ID: 36121609
29, Wu J, et al. CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis.Signal transduction and targeted therapy, PubMed ID: 36424379
30, Wu K, et al. Five-Minute Magnetic Nanoparticle Spectroscopy-Based Bioassay for Ultrafast Detection of SARS-CoV-2 Spike Protein.ACS applied nano materials, PubMed ID: 36570474
31, Langel SN, et al. Dam-Infant Rhesus Macaque Pairs to Dissect Age-Dependent Responses to SARS-CoV-2 Infection.ImmunoHorizons, PubMed ID: 36547390
32, Emmenegger M, et al. Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling.STAR protocols, PubMed ID: 36853663
33, Park KS, et al. Ultra-sensitive label-free SERS biosensor with high-throughput screened DNA aptamer for universal detection of SARS-CoV-2 variants from clinical samples.Biosensors & bioelectronics, PubMed ID: 36940632
34, Adams LE, et al. Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination.Cell reports, PubMed ID: 37000623
35, Tai W, et al. An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants.Nature communications, PubMed ID: 37221158
36, Wouters E, et al. Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters.EBioMedicine, PubMed ID: 37148586
37, Han X, et al. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines.Nature nanotechnology, PubMed ID: 37365276
38, Chen X, et al. PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness.Vaccine, PubMed ID: 37400286
39, Tong X, et al. Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination.Nature communications, PubMed ID: 37443074
40, Mulgaonkar N, et al. Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant.Pharmaceutics, PubMed ID: 37514075
41, Ou BS, et al. Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Improve Vaccine Immunomodulation.bioRxiv : the preprint server for biology, PubMed ID: 37577608
42, Chiuppesi F, et al. Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy.Vaccines, PubMed ID: 37766168
43, Stewart-Jones GBE, et al. Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.Science translational medicine, PubMed ID: 37703353
44, Guo Y, et al. The cryo-EM structure of homotetrameric attachment glycoprotein from langya henipavirus.Nature communications, PubMed ID: 38280880
45, Khan I, et al. Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1.Nature communications, PubMed ID: 38167417
46, Poulakou G, et al. Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19.Frontiers in immunology, PubMed ID: 38694503
47, Kinoshita M, et al. Immunological Response to Subcutaneous and Intranasal Administration of SARS-CoV-2 Spike Protein in Mice.Vaccines, PubMed ID: 38675726
48, Maji D, et al. Enhancing In Vivo Electroporation Efficiency through Hyaluronidase: Insights into Plasmid Distribution and Optimization Strategies.Pharmaceutics, PubMed ID: 38675208
49, Park S, et al. An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation.Nature communications, PubMed ID: 38643233
50, Jansen EB, et al. PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females.Scientific reports, PubMed ID: 38684819
51, Ou BS, et al. Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses.Science advances, PubMed ID: 39110802